# Elevar Therapeutics, Inc. – FDA Inspection, May 20, 2026

Source: https://www.keypedia.com/records/fda_inspections/elevar-therapeutics-inc/e2af1881-6c26-4bf1-8066-a70eb21ed836
Source feed: FDA_Inspections

> FDA inspection 1318414 of Elevar Therapeutics, Inc., May 20, 2026. 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1318414
- Company Name: Elevar Therapeutics, Inc.
- Inspection Date: 2026-05-20
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 1

## Related Officers

- [Company Rep](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)

Company: https://www.keypedia.com/companies/elevar-therapeutics-inc/f71beff4-164c-4514-bfe8-73d4e3d32173

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248